Robot vs. surgeon: which is better for uterine cancer surgery?

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Randomized Study: Inclusion Criteria: * Patient with low-risk or intermediate-risk endometrial carcinoma (on pre-operative workup including histology on endometrial biopsy and pelvic and lumbo-aortic MRI) , i.e. patients with endometrioid-type endometrial adenocarcinoma cancer low-grade (grade 1 or 2) and pre-therapeutic FIGO stage I (FIGO classification 2023) on MRI. * Indication for minimally invasive STH (laparoscopy) given by the surgeon during the pre-op consultation. * Patient accepts the matching of pseudonymized data with the French National Health Data System (SNDS) * Major patient. * Patient having received information on the protocol and having signed a consent form, thus accepting randomization in the robot-assisted intervention group versus conventional laparoscopy. Non Inclusion Criteria: * Patient operated on by a surgeon with less than 30 cases of robotic surgery in the last year and/or with less than 50 cases of total robotic experience at the time of patient inclusion. * Patient refuses to participate in randomized controlled trial (refuses randomization) * The surgeon refuses the patient's participation in the randomized controlled trial (does not wish to randomize the patient). * The center does not have a robot * The center does not have a laparoscopic column with fluorescence * Person under legal protection (safeguard of justice, curatorship, guardianship) or person deprived of liberty; * Patient not affiliated to a French social security scheme * Patient participating in another interventional trial or in Jardé off-label research that impacts study data, or in RIPH3 that impacts study data * Pregnant or breast-feeding patient Exclusion criteria : * Minimally invasive procedure contraindicated by pre-operative anesthesia. * Patient operated on by a robot other than one of the intuitive robot variants (Si, X and Xi). Prospective cohort: Inclusion Criteria: * Patient with low-risk or intermediate-risk endometrial carcinoma (on pre-operative workup including histology on endometrial biopsy and pelvic and lumbo-aortic MRI) , i.e. patient with endometrioid-type endometrial adenocarcinoma cancer low-grade (grade 1 or 2) and pre-therapeutic FIGO stage I (FIGO classification 2023) on MRI . * Indication for minimally invasive STH (laparoscopy) given by the surgeon during the pre-op consultation. * Patient accepts the matching of pseudonymized data with the French National Health Data System (SNDS) * Major patient. * Patient not included in randomized controlled trial because : * Patient refuses to participate in randomized controlled trial (refusing randomization) * The surgeon refuses the patient's participation in the randomized controlled trial (does not wish to randomize the patient) * The center does not have a robot * The center does not have a laparoscopic column with fluorescence * The surgeon does not meet the required learning curve criteria (as a reminder: ≥ 30 cases of robotic surgery in the last year and with total robotic experience ≥ 50 procedures ) at the time of patient inclusion * Patient has been informed about the protocol and has signed a consent form. Non Inclusion Criteria: * Person under legal protection (safeguard of justice, curatorship, guardianship) or person deprived of liberty; * Patient not affiliated to a French social security scheme * Patient participating in another interventional trial or in Jardé off-label research that impacts study data, or in RIPH3 that impacts study data * Pregnant or breast-feeding patient Exclusion criteria : * Minimally invasive procedure contraindicated by pre-operative anesthesia. * Patient operated on by a robot other than one of the intuitive robot variants (Si, X and Xi). Retrospective cohort: Inclusion Criteria: * Patient with low-risk or intermediate-risk endometrial carcinoma (on pre-operative workup including histology on endometrial biopsy and pelvic and lumbo-aortic MRI) , i.e. patient with endometrioid-type endometrial adenocarcinoma cancer low-grade (grade 1 or 2) and pre-therapeutic FIGO stage I (FIGO classification 2023) on MRI). * STH performed during the inclusion period of the randomized controlled trial and/or the prospective cohortat a participating center, regardless of the approach used, not included in the randomized controlled trial and in the prospective cohort. * Patient not objecting to the collection and use of her data * Patient of legal age. Non Inclusion Criteria: * Person under legal protection (safeguard of justice, curatorship, guardianship) or person deprived of liberty; * Patient not affiliated to a French social security scheme Surgeons : Inclusion Criteria: * Surgeon performing hysterectomy on patients included in the randomized study and/or prospective cohort * Surgeon not objecting to the collection and use of his data Non- inclusion Criteria: None First surgical assistance in the field : Inclusion Criteria: * First surgical assistance in the field performing hysterectomy on patients included in the randomized study and/or prospective cohort * First surgical assistance in the field not objecting to the collection and use of his data Non- inclusion Criteria: None